[Stereological analysis of ultrastructural changes in cardiomyocytes during adriblastina-induced cardiomyopathy]

Area of Science:

• Cardiology
• Toxicology
• Cell Biology

Context:

• Adriablastine (doxorubicin) is an anthracycline antibiotic used in chemotherapy.
• Cardiotoxicity is a known side effect of anthracycline treatment.
• Understanding the cellular mechanisms of adriablastine cardiotoxicity is crucial for patient management.

Purpose:

• To investigate the morphological changes in cardiomyocytes following adriablastine administration in a rat model.
• To identify cellular indicators of adriablastine-induced cardiotoxicity.

Summary:

• Administration of adriablastine to white rats resulted in a decrease in cardiomyocyte volume.
• Morphological alterations included dystrophia, lysis of myofibrils, and reduced mitochondrial surface density.
• Accumulations of myelin bodies and diffuse myolysis were observed, indicating potential lipid peroxidation.

Impact:

• The study identifies myelin bodies and diffuse myolysis as potential morphological markers for adriablastine-induced cardiomyopathy.
• Findings contribute to the understanding of the cellular pathology of anthracycline cardiotoxicity.
• This research may inform strategies to mitigate adriablastine's adverse cardiac effects.